Calcitriol D6
(Synonyms: 1α,25-dihydroxy Vitamin D3-d6; 骨化三醇 D6) 目录号 : GC35589An internal standard for the quantification of calcitriol
Cas No.:78782-99-7
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Calcitriol-d6 is intended for use as an internal standard for the quantification of calcitriol by GC- or LC-MS. Calcitriol is a vitamin D3 receptor agonist and an active metabolite of vitamin D3 .1,2 It is formed via a multi-step process, in which vitamin D3 undergoes hydroxylation to 25-hydroxy vitamin D3 in the liver, followed by further hydroxylation at the 1α-position in the kidney. Calcitriol binds to the vitamin D3 receptor (Kd = 16 pM) and induces differentiation of U937 acute monocytic leukemia cells (EC50 = 2,000 pM).3 It induces cell cycle arrest at the S phase and apoptosis in primary adenomatous and hyperplastic human parathyroid cells when used at a concentration of 10 nM.4 Calcitriol (0.65 nmol/animal) increases bone calcium mobilization in chicks on a low-calcium diet.2 It stimulates calcium absorption in the intestines in a chick model of rickets induced by a vitamin D3-deficient diet when administered at a dose of 25 ?g/animal.1 Formulations containing calcitriol have been used in the treatment of hypocalcemia.
1.Lawson, D.E., Fraser, D.R., Kodicek, E., et al.Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolismNature230(5291)228-230(1971) 2.Haussler, M.R., Zerwekh, J.E., Hesse, R.H., et al.Biological activity of 1α-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3Proc. Natl. Acad. Sci. USA70(8)2248-2252(1973) 3.Binderup, L., Latini, S., Binderup, E., et al.20-epi-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responsesBiochem. Pharmacol.42(8)1569-1575(1991) 4.Canalejo, A., Almadén, Y., Torregrosa, V., et al.The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosisJ. Am. Soc. Nephrol.11(10)1865-1872(2000)
Cas No. | 78782-99-7 | SDF | |
别名 | 1α,25-dihydroxy Vitamin D3-d6; 骨化三醇 D6 | ||
Canonical SMILES | C=C1/C(C[C@H](C[C@@H]1O)O)=C\C=C2CCC[C@]3(C)[C@@H]([C@@H](CCCC(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)C)CC[C@@]/23[H] | ||
分子式 | C27H38D6O3 | 分子量 | 422.67 |
溶解度 | DMSO : 50 mg/mL (118.30 mM; Need ultrasonic) | 储存条件 | Store at -20°C,unstable in solution, ready to use. |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.3659 mL | 11.8296 mL | 23.6591 mL |
5 mM | 0.4732 mL | 2.3659 mL | 4.7318 mL |
10 mM | 0.2366 mL | 1.183 mL | 2.3659 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。